As a result of a large pool of scientific talent, world-class information technology industry, and vibrant pharmaceutical sector, the Indian biotech industry has stupendously grown over the past few years, according to a news report added to the offering of Research and Markets.
During the 2005-2009 fiscal years, the industry witnessed an impressive compound annual growth rate (CAGR) of around 26.5% and generated total revenue of 121.4 billion rupees ($2.4 billion) in 2009. Moreover, the industry has been able to survive successfully amid the global financial turmoil. Government initiatives, like set up of more biotech parks and encouragement to public-private-partnerships, provided cushion to the biotech industry against tough economic conditions of recession.
Expected to grow further
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze